世界の皮膚・軟部組織感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Skin and Soft Tissue Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4865 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、皮膚・軟部組織感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗真菌剤、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・皮膚・軟部組織感染症治療の市場動向 ・企業の競争状況、市場シェア ・皮膚・軟部組織感染症治療の種類別市場規模と予測2016-2027（抗生物質、抗真菌剤、その他） ・皮膚・軟部組織感染症治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他） ・皮膚・軟部組織感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚・軟部組織感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚・軟部組織感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚・軟部組織感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚・軟部組織感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Wockhardt Limited、Atox Bio Inc.、Durata Therapeutics (Teva)、Basilea Pharmaceutica AG、Melinta Therapeutics、Takeda Pharmaceutical） ・結論

Market Analysis and Insights: Global Skin and Soft Tissue Infection Treatment Market
The global Skin and Soft Tissue Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin and Soft Tissue Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin and Soft Tissue Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin and Soft Tissue Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin and Soft Tissue Infection Treatment market.

Global Skin and Soft Tissue Infection Treatment Scope and Market Size
Skin and Soft Tissue Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin and Soft Tissue Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Anti-Fungal Agents
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Wockhardt Limited
Atox Bio Inc.
Durata Therapeutics (Teva)
Basilea Pharmaceutica AG
Melinta Therapeutics
Takeda Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin and Soft Tissue Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Anti-Fungal Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Skin and Soft Tissue Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Skin and Soft Tissue Infection Treatment Market Perspective (2016-2027)
2.2 Skin and Soft Tissue Infection Treatment Growth Trends by Regions
2.2.1 Skin and Soft Tissue Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin and Soft Tissue Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Skin and Soft Tissue Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Skin and Soft Tissue Infection Treatment Industry Dynamic
2.3.1 Skin and Soft Tissue Infection Treatment Market Trends
2.3.2 Skin and Soft Tissue Infection Treatment Market Drivers
2.3.3 Skin and Soft Tissue Infection Treatment Market Challenges
2.3.4 Skin and Soft Tissue Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Skin and Soft Tissue Infection Treatment Players by Revenue
3.1.1 Global Top Skin and Soft Tissue Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Skin and Soft Tissue Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin and Soft Tissue Infection Treatment Revenue
3.4 Global Skin and Soft Tissue Infection Treatment Market Concentration Ratio
3.4.1 Global Skin and Soft Tissue Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin and Soft Tissue Infection Treatment Revenue in 2020
3.5 Skin and Soft Tissue Infection Treatment Key Players Head office and Area Served
3.6 Key Players Skin and Soft Tissue Infection Treatment Product Solution and Service
3.7 Date of Enter into Skin and Soft Tissue Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Skin and Soft Tissue Infection Treatment Breakdown Data by Type
4.1 Global Skin and Soft Tissue Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Skin and Soft Tissue Infection Treatment Breakdown Data by Application
5.1 Global Skin and Soft Tissue Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Skin and Soft Tissue Infection Treatment Market Size (2016-2027)
6.2 North America Skin and Soft Tissue Infection Treatment Market Size by Type
6.2.1 North America Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2027)
6.3 North America Skin and Soft Tissue Infection Treatment Market Size by Application
6.3.1 North America Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2027)
6.4 North America Skin and Soft Tissue Infection Treatment Market Size by Country
6.4.1 North America Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Skin and Soft Tissue Infection Treatment Market Size (2016-2027)
7.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Type
7.2.1 Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Skin and Soft Tissue Infection Treatment Market Size by Application
7.3.1 Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Skin and Soft Tissue Infection Treatment Market Size by Country
7.4.1 Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Skin and Soft Tissue Infection Treatment Market Size (2016-2027)
9.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type
9.2.1 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application
9.3.1 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Skin and Soft Tissue Infection Treatment Market Size by Country
9.4.1 Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Skin and Soft Tissue Infection Treatment Introduction
11.1.4 Merck Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Wockhardt Limited
11.2.1 Wockhardt Limited Company Details
11.2.2 Wockhardt Limited Business Overview
11.2.3 Wockhardt Limited Skin and Soft Tissue Infection Treatment Introduction
11.2.4 Wockhardt Limited Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.2.5 Wockhardt Limited Recent Development
11.3 Atox Bio Inc.
11.3.1 Atox Bio Inc. Company Details
11.3.2 Atox Bio Inc. Business Overview
11.3.3 Atox Bio Inc. Skin and Soft Tissue Infection Treatment Introduction
11.3.4 Atox Bio Inc. Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.3.5 Atox Bio Inc. Recent Development
11.4 Durata Therapeutics (Teva)
11.4.1 Durata Therapeutics (Teva) Company Details
11.4.2 Durata Therapeutics (Teva) Business Overview
11.4.3 Durata Therapeutics (Teva) Skin and Soft Tissue Infection Treatment Introduction
11.4.4 Durata Therapeutics (Teva) Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.4.5 Durata Therapeutics (Teva) Recent Development
11.5 Basilea Pharmaceutica AG
11.5.1 Basilea Pharmaceutica AG Company Details
11.5.2 Basilea Pharmaceutica AG Business Overview
11.5.3 Basilea Pharmaceutica AG Skin and Soft Tissue Infection Treatment Introduction
11.5.4 Basilea Pharmaceutica AG Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.5.5 Basilea Pharmaceutica AG Recent Development
11.6 Melinta Therapeutics
11.6.1 Melinta Therapeutics Company Details
11.6.2 Melinta Therapeutics Business Overview
11.6.3 Melinta Therapeutics Skin and Soft Tissue Infection Treatment Introduction
11.6.4 Melinta Therapeutics Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.6.5 Melinta Therapeutics Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Skin and Soft Tissue Infection Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Skin and Soft Tissue Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Anti-Fungal Agents
Table 4. Key Players of Others
Table 5. Global Skin and Soft Tissue Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Skin and Soft Tissue Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Skin and Soft Tissue Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Skin and Soft Tissue Infection Treatment Market Share by Regions (2016-2021)
Table 9. Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Skin and Soft Tissue Infection Treatment Market Share by Regions (2022-2027)
Table 11. Skin and Soft Tissue Infection Treatment Market Trends
Table 12. Skin and Soft Tissue Infection Treatment Market Drivers
Table 13. Skin and Soft Tissue Infection Treatment Market Challenges
Table 14. Skin and Soft Tissue Infection Treatment Market Restraints
Table 15. Global Skin and Soft Tissue Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Skin and Soft Tissue Infection Treatment Market Share by Players (2016-2021)
Table 17. Global Top Skin and Soft Tissue Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin and Soft Tissue Infection Treatment as of 2020)
Table 18. Ranking of Global Top Skin and Soft Tissue Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Skin and Soft Tissue Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Skin and Soft Tissue Infection Treatment Product Solution and Service
Table 22. Date of Enter into Skin and Soft Tissue Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Skin and Soft Tissue Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Skin and Soft Tissue Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Skin and Soft Tissue Infection Treatment Product
Table 65. Merck Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Wockhardt Limited Company Details
Table 68. Wockhardt Limited Business Overview
Table 69. Wockhardt Limited Skin and Soft Tissue Infection Treatment Product
Table 70. Wockhardt Limited Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Wockhardt Limited Recent Development
Table 72. Atox Bio Inc. Company Details
Table 73. Atox Bio Inc. Business Overview
Table 74. Atox Bio Inc. Skin and Soft Tissue Infection Treatment Product
Table 75. Atox Bio Inc. Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Atox Bio Inc. Recent Development
Table 77. Durata Therapeutics (Teva) Company Details
Table 78. Durata Therapeutics (Teva) Business Overview
Table 79. Durata Therapeutics (Teva) Skin and Soft Tissue Infection Treatment Product
Table 80. Durata Therapeutics (Teva) Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Durata Therapeutics (Teva) Recent Development
Table 82. Basilea Pharmaceutica AG Company Details
Table 83. Basilea Pharmaceutica AG Business Overview
Table 84. Basilea Pharmaceutica AG Skin and Soft Tissue Infection Treatment Product
Table 85. Basilea Pharmaceutica AG Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. Basilea Pharmaceutica AG Recent Development
Table 87. Melinta Therapeutics Company Details
Table 88. Melinta Therapeutics Business Overview
Table 89. Melinta Therapeutics Skin and Soft Tissue Infection Treatment Product
Table 90. Melinta Therapeutics Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 91. Melinta Therapeutics Recent Development
Table 92. Takeda Pharmaceutical Company Details
Table 93. Takeda Pharmaceutical Business Overview
Table 94. Takeda Pharmaceutical Skin and Soft Tissue Infection Treatment Product
Table 95. Takeda Pharmaceutical Revenue in Skin and Soft Tissue Infection Treatment Business (2016-2021) & (US$ Million)
Table 96. Takeda Pharmaceutical Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin and Soft Tissue Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Anti-Fungal Agents Features
Figure 4. Others Features
Figure 5. Global Skin and Soft Tissue Infection Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Skin and Soft Tissue Infection Treatment Report Years Considered
Figure 11. Global Skin and Soft Tissue Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Skin and Soft Tissue Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Skin and Soft Tissue Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Skin and Soft Tissue Infection Treatment Market Share by Regions (2022-2027)
Figure 15. Global Skin and Soft Tissue Infection Treatment Market Share by Players in 2020
Figure 16. Global Top Skin and Soft Tissue Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin and Soft Tissue Infection Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Skin and Soft Tissue Infection Treatment Revenue in 2020
Figure 18. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Skin and Soft Tissue Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Skin and Soft Tissue Infection Treatment Market Share by Type (2016-2027)
Figure 22. North America Skin and Soft Tissue Infection Treatment Market Share by Application (2016-2027)
Figure 23. North America Skin and Soft Tissue Infection Treatment Market Share by Country (2016-2027)
Figure 24. United States Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Skin and Soft Tissue Infection Treatment Market Share by Type (2016-2027)
Figure 28. Europe Skin and Soft Tissue Infection Treatment Market Share by Application (2016-2027)
Figure 29. Europe Skin and Soft Tissue Infection Treatment Market Share by Country (2016-2027)
Figure 30. Germany Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Skin and Soft Tissue Infection Treatment Market Share by Region (2016-2027)
Figure 40. China Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Skin and Soft Tissue Infection Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Skin and Soft Tissue Infection Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Skin and Soft Tissue Infection Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Skin and Soft Tissue Infection Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Skin and Soft Tissue Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 60. Wockhardt Limited Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 61. Atox Bio Inc. Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 62. Durata Therapeutics (Teva) Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 63. Basilea Pharmaceutica AG Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 64. Melinta Therapeutics Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Skin and Soft Tissue Infection Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---